Grifols S.A.

E:GRF 
(MADRID) 
 
23.48
Updated 21/03/2019
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 1,315,427
High 23.84
Low 23.41
Open 23.75
ISIN ES0171996087
Prev close 23.48
# of shares -
Market cap -
Intraday

Market closed
Grifols S.A.
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  23.48 -2.2% Stock price decreasing 1.0% Stock price increasing 3.8% Stock price increasing -3.8% Stock price decreasing 6.8% Stock price increasing
Powered by TradingView

Company profile

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 79% of sales in 2017. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics grew to almost 20% of revenue in 2014 with the acquisition of Novartis' diagnostics unit.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 March 2019 11:17:18
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190320.1 - EUROWEB1 - 2019-03-23 12:17:18 - 2019-03-23 11:17:18 - 1000 - Website: OKAY